Pharmaceuticals, Biotechnology and Life Sciences
Employers can join the waitlist today to learn how the company is making high-demand benefits—starting with GLP-1s for obesity management—more…
Parse’s GigaLab to provide industry leading, large-scale, single cell services to support Tahoe’s development of foundational biological datasets SEATTLE–(BUSINESS WIRE)–Parse…
NEW YORK–(BUSINESS WIRE)–Accenture (NYSE: ACN) has invested in Ryght AI, a platform provider that modernizes how clinical research is designed…
Registration-directed program also includes a second Phase 3 trial in males and a Phase 2/3 trial in females with pattern…
The U.S. FDA assigned a target action date of April 8, 2026 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #FDA—Bristol Myers Squibb (NYSE: BMY)…
WASHINGTON–(BUSINESS WIRE)–Today, ACRO announced that its Board of Directors elected Cassandra “Sandy” Kennedy, Chief Quality, Regulatory Affairs, and Sustainability Officer…
Leadership Changes to Take Effect Following Conclusion of Ordinary General Meeting of Shareholders in March 2026 Announcement Follows Year of…
Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause and is associated…
MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2026…
TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”),…